Zobrazeno 1 - 10
of 24
pro vyhledávání: ''
Autor:
Eveline A.M. Heijnsdijk, Iris Lansdorp-Vogelaar, Sylvia Kaljouw, Elisabeth F. P. Peterse, L. De Jonge, I. M. C. M. de Kok, Erik E.L. Jansen, N. T. van Ravesteyn, Lindy M. Kregting
Publikováno v:
British Journal of Cancer
European Journal of Cancer
British Journal of Cancer, 124(9), 1516-1523. Nature Publishing Group
Web of Science
European Journal of Cancer
British Journal of Cancer, 124(9), 1516-1523. Nature Publishing Group
Web of Science
Background Many breast, cervical, and colorectal cancer screening programmes were disrupted due to the COVID-19 pandemic. This study aimed to estimate the effects of five restart strategies after the disruption on required screening capacity and canc
Publikováno v:
British Journal of Cancer
Background: The current study followed-up site-specific cancer risks in an unique cohort with 30 years’ follow-up after long-term low-dose-rate radiation exposure in Taiwan. Methods: Six thousand two hundred and forty two Taiwanese people received
Autor:
Gudridur H Olafsdottir, Elinborg J Olafsdottir, Bjarni A. Agnarsson, Hrefna Stefansdottir, Adalgeir Arason, Rodrigo Munoz Mitev, Kristin Alexiusdottir, R B Barkardottir, Jorunn E. Eyfjord, Steven A. Narod, Jon G. Jonasson, Laufey Tryggvadottir, Olafur A. Stefansson, Kristrun Olafsdottir, Vigdis Stefansdottir, Oskar T. Johannsson, Katrin Olafsdottir, Helgi Sigurdsson
Publikováno v:
British Journal of Cancer
Background: The impact of an inherited BRCA2 mutation on the prognosis of women with breast cancer has not been well documented. We studied the effects of oestrogen receptor (ER) status, other prognostic factors and treatments on survival in a large
Autor:
H Mason, Claire Hulme, Joachim Marti, Penny Wright, David Meads, Peter Hall, Alison Smith, A. Newsham, Laura Ashley, Galina Velikova, Helen Jones, Patrick B. Hamilton
Publikováno v:
British Journal of Cancer
BACKGROUND: The rising financial burden of cancer on health-care systems worldwide has led to the increased demand for evidence-based research on which to base reimbursement decisions. Economic evaluations are an integral component of this necessary
Autor:
Alberta Locatelli, Tiziana Digena, Luca Gianni, Lucia Viganò, Richard Cathomas, Elisa Gallerani, Cristiana Sessa, Angelica Fasolo, A Tessari, G. Del Conte, R. von Moos
Publikováno v:
British Journal of Cancer
Background: Olaparib, an oral PARP inhibitor, has shown antitumour activity as monotherapy in patients with germline BRCA1/2 (gBRCA)-mutated breast and ovarian cancer. This study evaluated olaparib capsules in combination with liposomal doxorubicin (
Publikováno v:
British Journal of Cancer
Background: Bevacizumab is an anti-vascular endothelial growth factor approved in association with paclitaxel or docetaxel as first line in patients (pts) with metastatic breast cancer. Rare cases of nasal septum perforations have been reported. We r
Autor:
Susan T. Mayne, Catherine A. McCarty, Amanda J. Cross, Louise A. Brinton, Barry I. Graubard, Xiaomei Ma, Regina G. Ziegler, Rashmi Sinha, Leah M. Ferrucci
Publikováno v:
British Journal of Cancer
Background: Epidemiological evidence on meat intake and breast cancer is inconsistent, with little research on potentially carcinogenic meat-related exposures. We investigated meat subtypes, cooking practices, meat mutagens, iron, and subsequent brea
Autor:
Douglas E. Horsman, Robert Royer, Charmaine Kim-Sing, Ping Sun, Steven A. Narod, Aletta Poll, Amy Finch, Jenna Scott, Kelly A. Metcalfe
Publikováno v:
British Journal of Cancer
Genetic testing for mutations in BRCA1 and BRCA2 is available in Canada for women with a significant family history of breast cancer. For the majority of tested women, a BRCA1 or BRCA2 mutation is not found, and counselling regarding breast cancer ri
Autor:
D Du Sart, J Deschênes, Isabelle Thiffault, N Hamel, David E. Goldgar, E. MacNamara, Victoria Marcus, Shannon Cowie, Wendy S. Meschino, William D. Foulkes, D. Farber, Fabrice Odefrey, Steven A. Narod, Tuya Pal, George Chong, T Graham, A K Watters, Susan McVety
Publikováno v:
British Journal of Cancer
There has been interest in the literature in the possible existence of a gene that predisposes to both breast cancer (BC) and colorectal cancer (CRC). We describe the detailed characterisation of one kindred, MON1080, with 10 cases of BC or CRC invas
Autor:
C. D'Amico, Domenico Sambiasi, Michele Guida, A Latorre, A. Mazzei, Francesco Schittulli, E. Crucitta, L. Caporusso, Annamaria Catino, Pietro Calabrese, M. De Lena, N. Silvestris, Vito Lorusso
Publikováno v:
British Journal of Cancer
The purpose of this study was to determine the maximum-tolerated dose of gemcitabine plus mitoxantrone in women with metastatic breast cancer (MBC) and to evaluate activity and toxicity of this combination in a phase II trial. Sixty-three patients wi